These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 5158780

  • 1. Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.
    Mones RJ, Elizan TS, Siegel GJ.
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):668-73. PubMed ID: 5158780
    [Abstract] [Full Text] [Related]

  • 2. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.
    Klawans HL, Weiner WJ.
    J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):427-30. PubMed ID: 4838914
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Problems and therapy of L-DOPA-induced dyskinesias].
    Völler GW, Deze J, Gundlach U, Muschard F.
    Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. L-dopa induced dyskinesias in 152 patients with Parkinson's disease.
    Mones RJ, Elizan TS, Siegel G.
    Trans Am Neurol Assoc; 1970 Nov; 95():286-7. PubMed ID: 5514393
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. L-dopa in Parkinsonism and the influence of previous thalamotomy.
    Hughes RC, Polgar JG, Weightman D, Walton JN.
    Br Med J; 1971 Jan 02; 1(5739):7-13. PubMed ID: 4923653
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. L-dopa in the treatment of Parkinsonism; a preliminary appraisal.
    Stellar S, Mandell S, Waltz JM, Cooper IS.
    J Neurosurg; 1970 Mar 02; 32(3):275-80. PubMed ID: 5416909
    [No Abstract] [Full Text] [Related]

  • 17. TRK-820, a selective kappa opioid receptor agonist, could effectively ameliorate L-DOPA-induced dyskinesia symptoms in a rat model of Parkinson's disease.
    Ikeda K, Yoshikawa S, Kurokawa T, Yuzawa N, Nakao K, Mochizuki H.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):42-8. PubMed ID: 19686730
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Parkinsonism with Laevo-dopa.
    Mawdsley C.
    Br Med J; 1970 Feb 07; 1(5692):331-7. PubMed ID: 4906702
    [Abstract] [Full Text] [Related]

  • 19. [Clinical experience with L-DOPA in the treatment of parkinsonism].
    Chiba T.
    No To Shinkei; 1970 Dec 07; 22(12):1399-405. PubMed ID: 5536833
    [No Abstract] [Full Text] [Related]

  • 20. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun 17; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.